Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy
Ended Project Grant Awarded Last action
- Award ID
- R44AI125060
- Recipient
-
Biovinc, LLC UEI NNEJMJ7KDAF1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,903,326
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $4,927,740.00 Federal
- $975,586.00 Non-federal
- Place of performance
- Pasadena, CA 91107, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $988,634 | $0 | |
| Amendment | $988,634 | $0 | |
| Amendment | $975,586 | $0 | |
| Amendment | $975,586 | $975,586 | |
| Original award | $999,300 | $0 |
Quick answers
Who received award R44AI125060?
R44AI125060 was awarded to Biovinc, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2016.
How much is award R44AI125060 worth?
$5,903,326 has been obligated on R44AI125060: $4,927,740 in federal funding and $975,586 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award